Prikaz rezultata 1 – 3 od 3 za pretragu 'Franz X. Gruber' Preskoči na sadržaj
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Napredno
  • Autor
  • Franz X. Gruber
Prikaz rezultata 1 – 3 od 3 za pretragu 'Franz X. Gruber', vrijeme upita: 0,02s Detaljiziraj rezultate
  1. 1
    Dynamical models of mutated chronic myelogenous leukemia cells for a post-imatinib treatment scenario: Response to dasatinib or nilotinib therapy.

    Dynamical models of mutated chronic myelogenous leukemia cells for a post-imatinib treatment scenario: Response to dasatinib or nilotinib therapy. od Clemens Woywod, Franz X Gruber, Richard A Engh, Tor Flå

    Izdano 2017-01-01
    Preuzmi cijeli tekst
    Članak
  2. 2
    The quantitative level of T315I mutated BCR-ABL predicts for major molecular response to second-line nilotinib or dasatinib treatment in patients with chronic myeloid leukemia

    The quantitative level of T315I mutated BCR-ABL predicts for major molecular response to second-line nilotinib or dasatinib treatment in patients with chronic myeloid leukemia od Thoralf Lange, Thomas Ernst, Franz X. Gruber, Jacqueline Maier, Michael Cross, Martin C. Müller, Dietger Niederwieser, Andreas Hochhaus, Markus Pfirrmann

    Izdano 2013-05-01
    Preuzmi cijeli tekst
    Članak
  3. 3
    A co-operative evaluation of different methods of detecting BCR-ABL kinase domain mutations in patients with chronic myeloid leukemia on second-line dasatinib or nilotinib therapy after failure of imatinib

    A co-operative evaluation of different methods of detecting BCR-ABL kinase domain mutations in patients with chronic myeloid leukemia on second-line dasatinib or nilotinib therapy... od Thomas Ernst, Franz X. Gruber, Oliver Pelz-Ackermann, Jacqueline Maier, Markus Pfirrmann, Martin C. Müller, Ingvild Mikkola, Kimmo Porkka, Dietger Niederwieser, Andreas Hochhaus, Thoralf Lange

    Izdano 2009-09-01
    Preuzmi cijeli tekst
    Članak

Alati za pretragu:

  • RSS vijesti
  • Pošalji pretragu e-mailom

Opcije pretrage

  • Povijest pretrage
  • Napredna pretraga

Pronađi više

  • Pregledaj katalog
  • Pregledaj abecednim redom
  • Istraži kanale
  • Rezervacije tečajeva
  • Novi predmeti

Trebaš pomoć?

  • Savjeti za pretragu
  • Upitaj knjižničara
  • Često postavljena pitanja